Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2017 (2017), Article ID 3274901, 4 pages
https://doi.org/10.1155/2017/3274901
Clinical Study

The Routine Use of Prophylactic Oxytocin in the Third Stage of Labor to Reduce Maternal Blood Loss

Department of Obstetrics and Gynecology, NHO Nagasaki Medical Center, Omura, Japan

Correspondence should be addressed to Ichiro Yasuhi; moc.cm-ikasagan@ihusay

Received 15 May 2017; Revised 19 July 2017; Accepted 24 July 2017; Published 11 September 2017

Academic Editor: Fabio Facchinetti

Copyright © 2017 Akiko Kuzume et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. To demonstrate whether or not the routine use of prophylactic oxytocin (RUPO) reduces the blood loss and incidence of postpartum hemorrhaging (PPH). Methods. We used a prospective cohort and a historical control in a tertiary perinatal care center in Japan. In the prospective cohort, we introduced RUPO in April 2012 by infusing 10 units of oxytocin per 500 mL of normal saline into a venous line after anterior shoulder delivery (RUPO group). In the historical control, oxytocin was administered via a case-selective approach (historical control group). We included completed singleton vaginal deliveries and compared the volume of blood loss and the incidence of PPH between the groups. Results. We found a significantly lower volume of blood loss ( versus  mL, ) and a lower incidence of PPH (6.1% versus 14.0%, ) in the RUPO group () than in the control group (). Although the oxytocin dose was significantly higher in the RUPO group ( versus  IU, ), no adverse outcomes were observed to be associated with RUPO. Conclusions. The introduction of RUPO significantly reduced blood loss and the incidence of PPH during completed singleton vaginal deliveries without an increase in adverse effects.